These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 30061172)

  • 1. LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in papillary thyroid carcinoma.
    Shen Y; Xia E; Bhandari A; Wang X; Guo G
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
    Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
    J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA RP11-547D24.1 regulates proliferation and migration in papillary thyroid carcinoma: Identification and validation of a novel long noncoding RNA through integrated analysis of TCGA database.
    Guo K; Chen L; Wang Y; Qian K; Zheng X; Sun W; Sun T; Wu Y; Wang Z
    Cancer Med; 2019 Jun; 8(6):3105-3119. PubMed ID: 31044550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA CCND2-AS1 promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
    Xia E; Bhandari A; Shen Y; Zhou X; Sindan N; Xiang J; Guan Y; Yang F; Wang O
    Biochem Biophys Res Commun; 2018 Feb; 496(2):628-632. PubMed ID: 29366479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
    Zhang Z; Li SY; Zhang LB
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of long noncoding RNA SLC26A4-AS1 inhibits the epithelial-mesenchymal transition via the MAPK pathway in papillary thyroid carcinoma.
    Wang DP; Tang XZ; Liang QK; Zeng XJ; Yang JB; Xu J
    J Cell Physiol; 2020 Mar; 235(3):2403-2413. PubMed ID: 31556116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines.
    Wang Y; Bhandari A; Niu J; Yang F; Xia E; Yao Z; Jin Y; Zheng Z; Lv S; Wang O
    Hum Cell; 2019 Jul; 32(3):334-342. PubMed ID: 30805847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Knockdown of long non-coding RNA actin filament-associated protein 1 antisense RNA1 (AFAP1-AS1) inhibits epithelial-mesenchymal transition, invasion and migration of TPC-1 papillary thyroid cancer cells].
    Fan H; Dong Q; Yu J; Yin L; Sun X; Yang X; Zhang W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jan; 37(1):54-60. PubMed ID: 33441229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer.
    Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B
    Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
    Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
    Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
    Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
    Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNF185 antisense RNA 1 (RNF185-AS1) promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
    Liu D; Zhang M; Song Y; Yang N
    Anticancer Drugs; 2022 Jul; 33(6):595-606. PubMed ID: 35324519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
    Hou S; Lin Q; Guan F; Lin C
    J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA RPL34-AS1 inhibits cell proliferation and invasion while promoting apoptosis by competitively binding miR-3663-3p/RGS4 in papillary thyroid cancer.
    Ji L; Fan X; Zhou F; Gu J; Deng X
    J Cell Physiol; 2020 Apr; 235(4):3669-3678. PubMed ID: 31587286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma.
    Feng Z; Chen R; Huang N; Luo C
    Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of long non-coding RNA AFAP1-AS1 inhibits tumor growth, promotes apoptosis and decreases metastasis in thyroid cancer.
    Dai W; Tian Y; Jiang B; Chen W
    Biomed Pharmacother; 2018 Mar; 99():191-197. PubMed ID: 29331858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA SOCS2-AS1 promotes the progression of papillary thyroid cancer by destabilizing p53 protein.
    Zhang X; Zhang X; Yang G; Wan L; Yin F; Li H; Yin D
    Biochem Biophys Res Commun; 2023 Aug; 669():95-102. PubMed ID: 37267865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYC promotes the development of papillary thyroid carcinoma by inhibiting the expression of lncRNA PAX8‑AS1:28.
    Zhang Y; Li F; Chen J
    Oncol Rep; 2019 Apr; 41(4):2511-2517. PubMed ID: 30720110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA ABHD11-AS1 promotes tumor progression in papillary thyroid carcinoma by regulating EPS15L1/EGFR signaling pathway.
    Lu H; Zhu C; Chen Y; Ruan Y; Fan L; Chen Q; Wei Q
    Clin Transl Oncol; 2022 Jun; 24(6):1124-1133. PubMed ID: 35098448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOXD-AS1 is a predictor of clinical progression and functions as an oncogenic lncRNAs in papillary thyroid cancer.
    Xu K; Feng Y
    J Cell Biochem; 2019 Apr; 120(4):5326-5332. PubMed ID: 30317670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.